CoChat

Putative neuroprotective pharmacotherapies to target the staged progression of mental illness

Open access
Robertson, Oliver D., Coronado, Nieves G., Sethi, Rickinder, Berk, Michael, Dodd, Seetal · 2019 · Early Intervention in Psychiatry
Cited by 52

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Abstract

Aim: Neuropsychiatric disorders including depression, bipolar and schizophrenia frequently exhibit a neuroprogressive course from prodrome to chronicity. There are a range of agents exhibiting capacity to attenuate biological mechanisms associated with neuroprogression. This review will update the evidence for putative neuroprotective agents including clinical efficacy, mechanisms of action and limitations in current assessment tools, and identify novel agents with neuroprotective potential. Method: Data for this review were sourced from online databases PUBMED, Embase and Web of Science. Only data published since 2012 were included in this review, no data were excluded based on language or publication origin. Results: Each of the agents reviewed inhibit one or multiple pathways of neuroprogression including: inflammatory gene expression and cytokine release, oxidative and nitrosative stress, mitochondrial dysfunction, neurotrophin dysregulation and apoptotic signalling. Some demonstrate clinical efficacy in preventing neural damage or loss, relapse or cognitive/functional decline. Agents include: the psychotropic medications lithium, second generation antipsychotics and antidepressants; other pharmacological agents such as minocycline, aspirin, cyclooxygenase‐2 inhibitors, statins, ketamine and alpha‐2‐delta ligands; and others such as erythropoietin, oestrogen, leptin, N‐acetylcysteine, curcumin, melatonin and ebselen. Conclusions: Signals of evidence of clinical neuroprotection are evident for a number of candidate agents. Adjunctive use of multiple agents may present a viable avenue to clinical realization of neuroprotection. Definitive prospective studies of neuroprotection with multimodal assessment tools are required.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/eip.12775

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 38 references

Cited by

See all 52

Metadata

Authors
Robertson, O. D., Coronado, N. G., Sethi, R., Berk, M., & Dodd, S.
Venue
Early Intervention in Psychiatry
Publisher
Wiley
Published
2019-01-28
Volume
13
Issue
5
Pages
1032-1049
ISSN
  • 1751-7885 (ISSN-L)
  • 1751-7893
OpenAlex
W2911377666
Cited by
52
References
38
FWCI
4.31
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Putative neuroprotective pharmacotherapies to target the staged progression of mental illness. https://app.cochat.ai/papers/10.1111/eip.12775
The paper
Robertson, O. D., Coronado, N. G., Sethi, R., Berk, M., & Dodd, S. (2019). Putative neuroprotective pharmacotherapies to target the staged progression of mental illness. Early Intervention in Psychiatry. https://doi.org/10.1111/eip.12775

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.